Literature DB >> 28008191

Abnormal urinalysis on day 7 in patients with IgA vasculitis (Henoch-Schönlein purpura).

Nozomu Kawashima1, Jun-Ichi Kawada2, Yuichi Nishikado3, Yuma Kitase4, Sanae Ito5, Hideki Muramatsu2, Yoshiaki Sato6, Taichi Kato2, Jun Natsume2, Seiji Kojima2.   

Abstract

Rare progression to renal failure imposes a burden on children with IgA vasculitis (Henoch-Schönlein purpura, HSP). An abnormal urinalysis on day 7 (7d-UA) may be a surrogate marker for persistent nephritis, but this has not been established. We retrospectively analyzed the risk factors for persistent nephritis in a cohort of 138 children. Of 35 children with abnormal 7d-UA, 24 (69%) had an abnormal urinalysis 6 months after the diagnosis of HSP, which was significantly more than 6 of 103 children (6%) with normal 7d-UA (P < 0.0001). The negative predictive values for normal urinalysis and negative proteinuria 6 months after diagnosis were 0.94 (95% confidence interval [CI], 0.90-0.97) and 0.98 (95% CI, 0.95-0.99), respectively. When children with abnormal urinalysis 6 months after diagnosis were compared with those without, the following factors were significantly associated: age at diagnosis, abnormal urinalysis at diagnosis, abnormal 7d-UA, complement C3, steroid treatment, and presence of abdominal pain. However, multivariate analysis revealed that abnormal 7d-UA was the only significant risk factor for abnormal urinalysis 6 months after diagnosis (odds ratio 54.3, 95% CI 15.3-275, P = 1.89 × 10-6). Abnormal 7d-UA may be an independent risk factor for persistent nephritis, but this should be confirmed in a prospective study.

Entities:  

Keywords:  Henoch–Schönlein purpura; IgA vasculitis; abnormal urinalysis; complement C3; multivariate analysis

Year:  2016        PMID: 28008191      PMCID: PMC5159461          DOI: 10.18999/nagjms.78.4.359

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  17 in total

1.  Predictors of outcome in Henoch-Schönlein nephritis in children and adults.

Authors:  Rosanna Coppo; Simeone Andrulli; Alessandro Amore; Bruno Gianoglio; Giovanni Conti; Licia Peruzzi; Francesco Locatelli; Leonardo Cagnoli
Journal:  Am J Kidney Dis       Date:  2006-06       Impact factor: 8.860

2.  Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Arch Dis Child       Date:  2010-09-16       Impact factor: 3.791

3.  Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children.

Authors:  Outi Jauhola; Jaana Ronkainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Arch Dis Child       Date:  2010-09-18       Impact factor: 3.791

4.  Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura.

Authors:  R Coppo; G Mazzucco; L Cagnoli; A Lupo; F P Schena
Journal:  Nephrol Dial Transplant       Date:  1997-11       Impact factor: 5.992

Review 5.  Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review.

Authors:  H Narchi
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

6.  EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria.

Authors:  Seza Ozen; Angela Pistorio; Silvia M Iusan; Aysin Bakkaloglu; Troels Herlin; Riva Brik; Antonella Buoncompagni; Calin Lazar; Ilmay Bilge; Yosef Uziel; Donato Rigante; Luca Cantarini; Maria Odete Hilario; Clovis A Silva; Mauricio Alegria; Ximena Norambuena; Alexandre Belot; Yackov Berkun; Amparo Ibanez Estrella; Alma Nunzia Olivieri; Maria Giannina Alpigiani; Ingrida Rumba; Flavio Sztajnbok; Lana Tambic-Bukovac; Luciana Breda; Sulaiman Al-Mayouf; Dimitrina Mihaylova; Vyacheslav Chasnyk; Claudia Sengler; Maria Klein-Gitelman; Djamal Djeddi; Laura Nuno; Chris Pruunsild; Jurgen Brunner; Anuela Kondi; Karaman Pagava; Silvia Pederzoli; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2010-05       Impact factor: 19.103

7.  The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study.

Authors:  Jaana Ronkainen; Matti Nuutinen; Olli Koskimies
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

Review 8.  Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review.

Authors:  W Chartapisak; S Opastiraku; N S Willis; J C Craig; E M Hodson
Journal:  Arch Dis Child       Date:  2008-08-13       Impact factor: 3.791

Review 9.  Pediatric vasculitis.

Authors:  Pamela F Weiss
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

Review 10.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.